MBX Biosciences (MBX) Profit After Tax (2023 - 2026)
MBX Biosciences (MBX) reported Profit After Tax of -$23.5 million for Q1 2026, up 1.52% on a YoY basis from -$23.2 million in Q1 2025, and down 5.98% sequentially from -$22.2 million in Q4 2025.
MBX Biosciences (MBX) Profit After Tax (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Profit After Tax data on file, last reported at -$23.5 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 1.52% year-over-year to -$23.5 million; the trailing twelve-month figure through Mar 2026 stood at -$86.7 million (up 14.62% YoY), and the FY2025 full-year result was -$87.0 million, down 40.49% from the prior year.
- Profit After Tax eased to -$23.5 million in Q1 2026, from -$22.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $121000.0 in Q3 2024 to a low of -$62.0 million in Q4 2024.
- A 4-year average of -$20.0 million and a median of -$19.4 million in 2025 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax jumped 101.19% in 2024 and slumped 17966.12% in 2025, its largest moves.
- Tracing MBX's Profit After Tax over 4 years: stood at -$8.8 million in 2023, then sank by 600.81% to -$62.0 million in 2024, then surged by 64.19% to -$22.2 million in 2025, then retreated by 5.98% to -$23.5 million in 2026.
- Business Quant data shows MBX's Profit After Tax at -$23.5 million in Q1 2026, -$22.2 million in Q4 2025, and -$21.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | -23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.52 Mn |
| Dec 31, 2025 | -22.19 Mn |
| Sep 30, 2025 | -21.62 Mn |
| Jun 30, 2025 | -19.41 Mn |
| Mar 31, 2025 | -23.88 Mn |
| Dec 31, 2024 | -61.97 Mn |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | -15.86 Mn |
| Mar 31, 2024 | -12.34 Mn |
| Dec 31, 2023 | -8.84 Mn |
| Sep 30, 2023 | -10.15 Mn |